tiprankstipranks
Trending News
More News >
SAB Biotherapeutics (SABS)
NASDAQ:SABS
US Market

SAB Biotherapeutics (SABS) Revenue

Compare
312 Followers

SAB Biotherapeutics Revenue

SAB Biotherapeutics had a revenue of 0.00 in the quarter ending Sep 30, 2025, with ―. This bring the company's revenue in the last twelve months to 114.70K, Decreased 0.00%. In the fiscal year ending Mar 31, 2025, SAB Biotherapeutics had annual revenue of 1.32M with -40.94% growth.
Revenue (ttm)
114.70K
Revenue Growth
-92.42%
P/S Ratio
136.44
Revenue/Employee
$20,991
Employees
63
Market Cap
$180.43M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Mar 31, 2025
1.32M-916.59K-40.94%
Dec 31, 2023
2.24M-21.66M-90.63%
Mar 31, 2023
23.90M-36.97M-60.73%
Dec 31, 2021
60.88M5.64M+10.21%
Dec 31, 2020
55.24M51.80M+1,504.82%
Dec 31, 2019
3.44M